Skip to content

Depression: all studies

Page 756 of 1,034: studies 7,551 to 7,560 of 10,336, newest first. Back to the depression overview

Research

Occlusion of dopamine-dependent synaptic plasticity in the prefrontal cortex mediates the expression of depressive-like behavior and is modulated by ketamine

Scientific Reports June 30, 2022 Jacopo Lamanna, Francesco Isotti, Mattia Ferro et al.

Unpredictable chronic mild stress (CMS) is among the most popular protocols used to induce depressive-like behaviors such as anhedonia in rats. Differences in CMS protocols often result in variable degree of vulnerability, and the mechanisms behind stress resilience are of great interest in neuroscience due to their involvement in the development of psychiatric disorders, including major...

Mediating Mindfulness-Based Interventions with Virtual Reality in Non-Clinical Populations: The State-of-the-Art.

Healthcare June 29, 2022 Chiara Failla, Flavia Marino, Luca Bernardelli et al.

Mindfulness is one of the most popular psychotherapeutic techniques that help to promote good mental and physical health. Combining mindfulness with immersive virtual reality (VR) has been proven to be especially effective for a wide range of mood disorders for which traditional mindfulness has proven valuable. However, the vast majority of immersive VR-enhanced mindfulness applications have...

DOI: 10.3390/healthcare10071220 (opens in new tab) Full text (opens in new tab) Mindfulness Virtual reality Negative mood Non-clinical populations +1

Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review

Cureus June 28, 2022 Ann M. Inouye, Aaron Wolfgang 5 citations

The Food and Drug Administration (FDA) granted breakthrough therapy status to 3,4-methyl​enedioxy​methamphetamine-assisted therapy (MDMA-AT) in 2017 due to preliminary evidence supporting its efficacy and safety in treating post-traumatic stress disorder (PTSD). A series of six phase-II clinical trials studying MDMA-AT for treatment-resistant PTSD found that 54% of MDMA-AT full-dose...

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders

Frontiers in Pharmacology June 28, 2022 Nataliya S. Vorobyeva, Alena A. Kozlova 16 citations

Classical psychedelics represent a family of psychoactive substances with structural similarities to serotonin and affinity for serotonin receptors. A growing number of studies have found that psychedelics can be effective in treating various psychiatric conditions, including post-traumatic stress disorder, major depressive disorder, anxiety, and substance use disorders. Mental health disorders...

The effects of mindfulness-based interventions in COVID-19 times: a systematic review

Journal of Human Growth and Development June 23, 2022 Dara Fernanda Brito Duarte, Jaiany Rodrigues Libório, Giovana Macêdo Egídio Cavalcante et al. 28 citations

Introduction: the public health crisis caused by COVID-19, a disease caused by SARS-CoV-2, has imposed physical threats and psychological suffering on both infected patients and individuals who experience social isolation and various governmental restrictions, leading to the appearance of symptoms like anxiety, depression, as well as insomnia, stress, and changes in biological rhythm. In face...

Persistent Dissociation and its Neural Correlates Uniquely Predict Worse Outcomes after Trauma Exposure

American Journal of Psychiatry June 22, 2022 Lauren A M Lebois, N. Harnett, S. V. van Rooij et al.

Objective: Dissociation, a disruption or discontinuity in psychological functioning, is often linked with worse psychiatric symptoms; however, the prognostic value of dissociation after trauma is inconsistent. Determining whether trauma-related dissociation is uniquely predictive of later outcomes would enable early identification of at-risk trauma populations. We completed the largest...

Enhancing Final-Year Medical Students’ Clinical Examinations Performance via a Transdiagnostic ACT-Based Intervention

Sustainability June 21, 2022 Nicholas Tze Ping Pang, Eugene Boon Yau Koh, Mohd Amiruddin Mohd Kassim et al. 7 citations

Introduction: Performance anxiety is a transdiagnostic construct similar in both sports and clinical medical examinations. Given that acceptance and commitment therapy (ACT) and other similar therapies have transdiagnostic evidence in improving the performance of athletes, the same approach can be adopted for medical students in improving their performance during clinical examinations. This...

Comparative effects of abbreviated mindfulness or acupuncture protocols in Healthy People: a non-randomized feasibility study with one-month follow-up

Research, Society and Development June 21, 2022 Marcelo Vilela Machado João, Marcelo Demarzo, Ysao Yamamura et al. 2 citations

Background and aims: Evaluate the effects of the use of abbreviated mindfulness and acupuncture in healthy individuals, evaluating the levels of depression, anxiety, and life quality in an outpatient clinic of a Brazilian federal university. Methods: Comparison of two abbreviated interventions (mindfulness- and acupuncture-based) in a non-randomized pragmatic feasibility pilot study, with...

The Effectiveness of Mindfulness-Based Cognitive Therapy in the Management of Tinnitus.

The international tinnitus journal June 21, 2022 Chanchai Jariengprasert, Kasinee Watanapornmongkol, Sivaporn Kiatthanabumrung et al.

Mindfulness-based cognitive therapy (MBCT) has been suggested as an effective modality in reducing the effects of tinnitus and improving quality of life. This article aimed to compare the effectiveness of MBCT with that of standard treatment in the management of tinnitus in Thai patients. All participants were voluntarily divided into experimental MBCT and control groups depending on their...

DOI: 10.5935/0946-5448.20220001 (opens in new tab) Full text (opens in new tab) Cognitive behavioral therapy Mindfulness therapy Tinnitus

Sustained effects of single doses of classical psychedelics in humans.

Neuropsychopharmacology June 21, 2022 Gitte M. Knudsen 56 citations

The serotonergic classical psychedelics include compounds that primarily activate the brain's serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive...

DOI: 10.1038/s41386-022-01361-x (opens in new tab) Full text (opens in new tab) Psychedelics Mental health Therapeutic treatment Depression treatment +1